Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity

The incidence of metabolic syndrome continues to rise globally. In mice, intravenous administration of interleukin-22 (IL-22) ameliorates various disease phenotypes associated with diet-induced metabolic syndrome. In patients, oral treatment is favored over intravenous treatment, but methodologies t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:mSphere
Autors principals: Oh, Jee-Hwan, Schueler, Kathryn L., Stapleton, Donnie S., Alexander, Laura M., Yen, Chi-Liang Eric, Keller, Mark P., Attie, Alan D., van Pijkeren, Jan-Peter
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316485/
https://ncbi.nlm.nih.gov/pubmed/32581074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mSphere.00183-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars